13.06.19|Meir OrbachThe company listed on NYSE Thursday according to a post-IPO $650 million valuation
16.12.18|Lilach BaumerAccessFintech raised a $17.5 million Series A to further develop its risk and exception management services
14.11.17|Dror Reich and Lilach BaumerAllergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018